Efficacy, Tolerability and Safety of ALNA® in Patients With Benign Prostatic Syndrome (BPS)

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Study to assess efficacy, tolerability and safety parameters of a one month ALNA® - treatment after switch from Terazosin-treatment

Boehringer Ingelheim